RxDoctor Payments Data

Joy Wan, MD

Dermatology · Philadelphia, PANPI 1235498346

Payments from drug & device makers

What this record shows

This record is dominated by grants: $175,704 of the $175,738 with a category attached, or 100.0%. Pfizer accounts for 71.5% of it on its own, with 2 other manufacturers making up the rest. Reporting peaked in 2019 at $77,777 and has fallen 100.0% since, to $34 in 2022. Among dermatology clinicians in PA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$175,738in general payments, 2019–2025

Across 9 payments — averaging $19,526 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Pfizer$126K
  • AbbVie$50K
  • Janssen Research & Development, LLC$34
$182,525in research payments, 2019–2025

Across 4 payments — averaging $45,631 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Pfizer$150K
  • Eli Lilly$33K

What the payments were for

  • Grants$175,704100%
  • Food & beverage$340%

General payments by program year

19
20
21
22

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Pfizer6$125,704
AbbVie2$50,000
Janssen Research & Development, LLC1$34

How this compares

$175,738 in reported general payments places this provider in the 95th percentile of 626 dermatology providers in Pennsylvania.

See all dermatology providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$4,947
Medicare patients
33
Services billed
51

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other dermatology in Philadelphia

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →